New study finds pathways required for healing and regeneration are shared between mammals and lampreys.
Ocrelizumab has been licensed by EU regulators as a therapy for multiple sclerosis, the first ever drug to be approved for the primary progressive form of the disease.
Preliminary trial indicates signs of CTE in young epilepsy patients – but how strong is the evidence?
In this editorial from Biomarkers in Medicine, discover how axonal transporter proteins may be utilized as biomarkers for a variety of neurological disorders.
In this research article from Personalized Medicine, explore how disorders such as depression and schizophrenia have been linked to specific neurotransmitter receptor variations.
Discover how transcranial stimulation may be used as a therapy for cognitive impairment and Alzheimer’s disease in this review article from Neurodegenerative Disease Management